glp 1 agonist for type 1 diabetes Glucagon-like peptide-1 Frontiers | GLP-1 Receptor Agonists:
Description
Retatrutide: A Triple Agonist with Unprecedented Efficacy Retatrutide (LY3437943) is a novel triple incretin agonist that simultaneously targets the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
Understanding these medications, their mechanisms, and their barriers is essential to improving patient access and adherence
Diabetologia 54 , S38 (2011)
Discount GLP-1 Prices: Walmart, Costco, Sams Club, CVS Keep in mind you still need a prescription for any GLP-1 medication
Accessed 2/10/2026
Liu L, Shi H, Shi Y, Wang A, Guo N, Tao H, et al
